期刊文献+

间接免疫荧光法检测冠心病患者外周血单个核细胞PP65抗原 被引量:2

Detection of HCMV pp65 antigen in peripheral blood mononuclear cells of patients with CHD by indirect immunofluorescence assay
下载PDF
导出
摘要 目的:了解冠心病患者外周血单个核细胞巨细胞病毒活动感染情况,并探讨动脉粥样硬化与HCMV感染的关系。方法:运用间接免疫荧光的方法,对29例冠心病患者、39例其他心血管病患者以及42例正常对照组外周血单个核细胞巨细胞病毒PP65抗原进行检测,并运用免疫散射比浊法对各组CRP进行测定。结果:29例冠心病患者中巨细胞病毒pp65抗原阳性者7例,占24.1%;与其他心血管患者中巨细胞病毒pp65抗原阳性率(5.1%)以及正常对照组巨细胞病毒pp65抗原阳性率(2.4%)相比明显升高,29例冠心病患者CRP水平(5.06±1.79mg/L)也明显高于其它两组(P<0.05)。结论:冠心病患者外周血单个核细胞巨细胞病毒活动感染可能在动脉粥样硬化的发展过程中有重要作用。 Objective:To detect human eytomegalovims(HCMV) phosphoprotein 65 (pp65) in peripheral blood mononuclear cells ( PBMCs ) of patients with enronary beart disease(CHD), and to study the association between atherosclerosis and HCMV infection. Methods: HCMV #5 antigen in peripheral blood. leucocyte were detected by indirect immunofiuorescence assay in the group of 29 patients with coronary heart disease, and the group of 39 patiens with other heart disease, and 42 normal control, meanwhile the level of serum Creacfive protein (CRP) were detected with rate scat ter nephelometry in three groups Results: Positive rate of HCMV PP65 antigen in 29 patients with CHD was 24.1%, and the results was significantly higher than that in the group of 39 patiens with other heart disease(5.1% ), and 42 normal control(2.4 % ), ( P 〈 0.05 ). and The CRP level significantly higher in the patients with CHD( 5.064 ± 1.79 mg/L) than in the patients with other heart disease and normal control group. Conclusion: Active HCMV infection can occurs in patients with CHD, and this may play an important role in die process of atherogenesis.
作者 姚磊 张孝廉
出处 《激光杂志》 CAS CSCD 北大核心 2009年第4期85-86,共2页 Laser Journal
基金 重庆市科委自然基金项目(CSTC 2008BB5123)
关键词 冠心病 巨细胞病毒 PP65抗原 单个核细胞 CMV phosphoprotein 65 peripheral blood mononuclear cells coronary heart disease
  • 相关文献

参考文献10

二级参考文献34

  • 1朱新臣,魏春华,杨玉坤,石军锋,马荣耀,王天才.缺血性脑卒中患者的颈动脉粥样硬化研究[J].实用神经疾病杂志,2005,8(1):24-25. 被引量:31
  • 2姚磊,张征,董解菊,康铃,何作云.巨细胞病毒诱导体外人血管内皮细胞凋亡的实验研究[J].重庆医学,2006,35(6):512-514. 被引量:4
  • 3王嗣欣,周丽红,林大正,高燕军,朱艳娟,陈启东,董可辉.短暂性脑缺血发作与颅内外血管狭窄的关系[J].临床神经病学杂志,2006,19(4):299-301. 被引量:23
  • 4杜继臣,杨旭,蒲传强,牛小媛,魏利华.缺血性脑血管病患者颈动脉颅外段动脉粥样硬化的临床特征[J].临床神经病学杂志,2007,20(1):1-4. 被引量:37
  • 5[1]Hu W, Liu J, Niu S, et al. Prevalence of CMV in arterial walls and leukocytes in patients with atherosclerosis [J].Chin Med J, 2001,114(11):1208-1210.
  • 6[2]Adam E, Melnick JL, Probtsfield JL, et al. High levels of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis[J]. Lancet, 1987,2(8554):291-293.
  • 7[3]Prichard MN, Penfold ME, Duke GM, et al. A review of genetic differences between limited and extensively passaged human cytomegalovirus strains [J]. Rev Med Virol, 2001,11(3):191-200.
  • 8[4]Castillo JP, Kowalik TF. HCMV infection: modulating the cell cycle and cell death[J]. Int Rev Immunol, 2004,23(1-2):113-139.
  • 9[5]Lunardi C, Bason C, Corrocher R, et al. Induction of endothelial cell damage by hCMV molecular mimicry [J].Trends Immunol, 2005,26(1):19-24.
  • 10[6]Fong IW. Infections and their role in atherosclerotic vascular disease[J]. J Am Dent Assoc, 2002,133 (Suppl):7S-13S.

共引文献8

同被引文献47

  • 1Park JW,Kim WH,Shin SH,Kim JY Yun MR Park KJ Park HY. Visfatin exerts angiogenic effects on human umbilical vein endothelial cells through the roTOR signaling pathway[J].Biochimica Et Biophysica Acta,2011,(1813):763-771.
  • 2Wang BW,Lin CM,Wu GJ,Shyu KG. Tumor necrosis factor-a enhances hyperbaric oxygen-induced vidatin expression via JNK pathway in human coronary arterial endothelial cells[J].Journal of Biomedical Science,2011,(01).
  • 3Kim SR,Bae YH,Bae SK,Choi KS Yoon KH Koo TH Jang HO Yan I Kim KW Kwon YG Yoo MA Bae MK. Visfatin enhances ICAM-1 and VCAM-1 expression through ROS-dependent NF-kappaB activation in endothelial cells[J].Biochimica Et Biophysica Acta,2008,(05):886-895.
  • 4Liu SW,Qiao SB,Yuan JS,Liu DQ. Vistatin stimulates production of monocyte chemotactic protein-1 and interleukin-6 in human vein umbilical endothelial cells[J].Hormone and Metabolic Research,2009,(04):281,286.
  • 5Chen MP,Chung FM,Chang DM,Tsai JC,Huang HF,Shin SJ,Lee YJ. Elevateal plasma level of visfatin pre - B celt colony enhancing factor in patients with type 2 diabetes mellitus[J].Clin Endocr inolM etab,2006,(01):295-299.
  • 6Varma V,Yao-Borengasser A,Rasouli N,Bodies AM Phanavanh B Lee MJ Starks T Kern LM Spencer HJ 3rd McGehee RE Jr Fried SK Kern PA. Human visfatin expression:relationship to insulin sensitivity,mtramyocellular lipids,and inflammation[J].Journal of Clinical Endocrinology and Metabolism,2007,(02):666-672.
  • 7Adya R,Fan BK,Punn A,Chen J Randeva HS. Visihtin induces human endothelial VEGF and MMP22/9 production via MAPK and PI3K/Akt signalling pathways:novel insights into visfatin-induced angiogenesis[J].Cardiovascular Research,2008,(02):356-365.
  • 8Manfredo R,Jelena K S,Kaspar B,et al. Atherogenic dyslipidemia and oxidative stress:a new look[J].Translational Research,2009,153(5):217-223.
  • 9Mosca L,Appel U,Benjamin EJ,et al.Evidence-based guidelines for car- diovascular disease prevention in women[J].Circulation, 2004, 109(5) : 672-693.
  • 10HUG C,LODISH H F.Visfatin:a new adipokine[J].Science,2005 (307) : 366-367.

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部